当期报告
诺瓦瓦克斯医药(NVAX)
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001104659-25-084049 Act: 34 Size: 232 KB 网页链接
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001104659-25-084049 Act: 34 Size: 232 KB 网页链接